INM-755 (cannabinol) cream
755-201-EB
Phase 2 small_molecule completed
Quick answer
INM-755 (cannabinol) cream for Epidermolysis Bullosa Simplex is a Phase 2 program (small_molecule) at InMed Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- InMed Pharmaceuticals
- Indication
- Epidermolysis Bullosa Simplex
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed